New Delhi [India], October 29 (ANI): The Cabinet Committee on Economic Affairs (CCEA) on Thursday approved the Dam Rehabilitation and Improvement Project (DRIP) Phase II and Phase III to improve safety and operational performance of selected dams across the country.
Chandigarh (Punjab) [India], October 24 (ANI): Phase-II of the Rs 11,000 crore Urban Environment Improvement Programme (UEIP) was kickstarted on Saturday in Chandigarh by Punjab Chief Minister Captain Amarinder Singh with a virtual foundation-laying ceremony.
New Delhi [India], October 23 (ANI): In a major development, Drugs Controller General of India (DCGI) on Friday gave permission to Bharat Biotech for conducting Phase-III clinical trial for the indigenous COVID-19 vaccine - Covaxin.
New Delhi [India], October 22 (ANI): The expert panel at Central Drugs Standard Control Organisation (CDSCO) has recommended the top drugs regulator to grant permission to Bharat Biotech to conduct phase III clinical trial using indigenous covid19 vaccine--Covaxin, with subject to the condit
Chandigarh [India], October 15 (ANI): Congress leader Rahul Gandhi will launch phase II of Punjab's Smart Village Campaign virtually on October 17 to pave the way for the next phase of holistic development of the 13,000 plus villages across the state.
New Delhi [India], October 10 (ANI): The expert panel at Central Drugs Standard Control Organisation (CDSCO) has asked drug maker Bharat Biotech to submit safety and immunogenicity data from ongoing phase II trial in order to conduct phase III clinical trial of indigenous COVID-19 vaccine, C
New Delhi [India], October 2 (ANI): Indian pharma giant Dr Reddy's Laboratories (DRL) has submitted an application to the Drugs Controller General of India (DCGI) for its approval to perform Phase III clinical trials of the Russian COVID-19 vaccine Sputnik V in India, a government officia
New Delhi [India], September 25 (ANI): The Centre sanctioned 670 electric buses in Maharashtra, Goa, Gujarat, and Chandigarh as also 241 charging stations in Madhya Pradesh, Tamil Nadu, Kerala, Gujarat and Port Blair under Phase-II of FAME India Scheme, Union Environment Minister Prakash Jav
Pune (Maharashtra) [India], September 19 (ANI): Serum Institute of India (SII) is all set to begin phase three trials of the Covishield Vaccine developed by AstraZeneca and Oxford University at Sassoon General Hospital in Pune, the hospital administration said on Saturday.
London [UK], September 18 (ANI): An immunotherapy drug called 'avelumab' has been shown to significantly improve survival in patients with the most common type of bladder cancer, according to results from a phase III clinical trial.
New Delhi [India], Aug 19 (ANI): The Subject Expert Committee (SEC) at the Central Drugs Standard Control Organisation (CDSCO) has recommended that the country's top drug regulator grant permission for phase 3 clinical trial using Thymosin @-1 injection 1.6 mg on moderate to severe COVID-19
New Delhi [India], Aug 3 (ANI): The Drugs Controller General of India (DCGI) gave approval to Serum Institute of India, Pune to conduct Phase II+III clinical trials of Oxford University-Astra Zeneca COVID-19 vaccine (COVISHIELD) in India, said the Ministry of Health and Family Welfare on